Although there have been attempts to characterize the oncogenic effect of BRD4 amplification in HGSOC [10], the exact mechanism by which BRD4 elicits ovarian tumor promotion is still a matter of scientific debate. The gene discussed is BRD4; the disease is ovarian neoplasm.